BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6465199)

  • 1. Pyruvate kinase in fetal plasma and amniotic fluid unsuccessful for the prenatal diagnosis of Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Am J Med Genet; 1984 Jun; 18(2):231-5. PubMed ID: 6465199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate-kinase (PK) and creatine-kinase (CK) in normal pregnancy and its implication in genetic counseling of Duchenne muscular dystrophy (DMD).
    Zatz M; Karp LE; Rogatko A
    Am J Med Genet; 1982 Nov; 13(3):257-62. PubMed ID: 7180871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal plasma carbonic anhydrase III in prenatal diagnosis of Duchenne muscular dystrophy.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL; Rodeck C
    Am J Med Genet; 1985 Jan; 20(1):115-22. PubMed ID: 3918446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal-blood creatine phosphokinase in the diagnosis of Duchenne's muscular dystrophy.
    N Engl J Med; 1978 Jun; 298(26):1479-80. PubMed ID: 652021
    [No Abstract]   [Full Text] [Related]  

  • 5. False elevation of amniotic fluid enzymes of relevance for prenatal diagnosis: creatine kinase measurement in relation to Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Prenat Diagn; 1984; 4(1):35-42. PubMed ID: 6728825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prenatal diagnosis of Duchenne muscular dystrophy by fetoscopic muscle biopsy. Report of a case].
    Guo Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Feb; 23(1):35-7, 63. PubMed ID: 2347279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine kinase estimation in pure fetal blood samples for the prenatal diagnosis of Duchenne muscular dystrophy.
    Edwards RJ; Watts DC; Watts RL; Rodeck CH
    Prenat Diagn; 1984; 4(4):267-77. PubMed ID: 6483787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Errors in plasma creatine kinase estimations on fetal blood samples resulting from contamination with amniotic fluid and maternal blood: relevance for the prenatal diagnosis of Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Prenat Diagn; 1984; 4(2):119-34. PubMed ID: 6739434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma creatine kinase and myoglobin levels, before and after abortion, in human fetuses at risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    Am J Med Genet; 1983 Jul; 15(3):475-82. PubMed ID: 6881213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In utero fetal muscle biopsy for the diagnosis of Duchenne muscular dystrophy in a female fetus "suddenly at risk".
    Evans MI; Farrell SA; Greb A; Ray P; Johnson MP; Hoffman EP
    Am J Med Genet; 1993 May; 46(3):309-12. PubMed ID: 8488877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creatine-kinase (CK) and pyruvate-kinase (PK) activities in cord blood of normal newborn infants: application to Duchenne muscular dystrophy screening programs.
    Passos MR; Zatz M
    Am J Med Genet; 1983 Nov; 16(3):367-72. PubMed ID: 6650572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle and serum enzymes and isoenzymes in muscular dystrophies.
    Ibrahim GA; Zweber BA; Awad EA
    Arch Phys Med Rehabil; 1981 Jun; 62(6):265-9. PubMed ID: 7235920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of Duchenne's muscular dystrophy.
    Mahoney MJ; Haseltine FP; Hobbins JC; Banker BQ; Caskey CT; Golbus MS
    N Engl J Med; 1977 Nov; 297(18):968-73. PubMed ID: 909543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of plasma myoglobin levels in the adult and fetus at-risk for Duchenne muscular dystrophy.
    Edwards RJ; Rodeck CH; Watts DC
    J Neurol Sci; 1984 Feb; 63(2):173-82. PubMed ID: 6707690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma/serum myoglobin in prenatal diagnosis of Duchenne muscular dystrophy.
    Török O; Szabó M; Veress L; Papp Z
    Am J Med Genet; 1986 Oct; 25(2):237-8. PubMed ID: 3777021
    [No Abstract]   [Full Text] [Related]  

  • 16. Failure of fetal creatine phosphokinase as a diagnostic indicator of Duchenne muscular dystrophy.
    Golbus MS; Stephens JD; Mahoney MJ; Hobbins JC; Haseltine FP; Caskey CT; Banker BQ
    N Engl J Med; 1979 Apr; 300(15):860-1. PubMed ID: 423925
    [No Abstract]   [Full Text] [Related]  

  • 17. Fetal muscle biopsy: collaborative experience with varied indications.
    Evans MI; Hoffman EP; Cadrin C; Johnson MP; Quintero RA; Golbus MS
    Obstet Gynecol; 1994 Dec; 84(6):913-7. PubMed ID: 7970469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 20. Antenatal diagnosis of Duchenne muscular dystrophy.
    Emery AE; Burt D; Dubowitz V; Rocker I; Donnai D; Harris R; Donnai P
    Lancet; 1979 Apr; 1(8121):847-9. PubMed ID: 86094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.